Creating a revolutionary stride in the field of infection prevention, the Food and Drug Administration (FDA) has recently launched a novel category of infection diagnostic tools. These tools are particularly crafted for the detection of nucleic acids of microorganisms, alongside markers that confer resistance to antimicrobials. As per a Federal Register notice circulated on May…